HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomohiko Ichikawa Selected Research

2- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acid

1/2022Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways.
1/2020Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomohiko Ichikawa Research Topics

Disease

96Prostatic Neoplasms (Prostate Cancer)
10/2022 - 01/2002
79Neoplasms (Cancer)
10/2022 - 02/2002
27Renal Cell Carcinoma (Grawitz Tumor)
10/2022 - 03/2002
27Neoplasm Metastasis (Metastasis)
06/2022 - 06/2002
11Urinary Bladder Neoplasms (Bladder Cancer)
10/2022 - 01/2016
9Carcinoma (Carcinomatosis)
07/2022 - 04/2009
8Hyperaldosteronism (Conn Syndrome)
01/2020 - 03/2012
6Disease Progression
01/2018 - 12/2006
6Carcinogenesis
08/2015 - 09/2003
5Pain (Aches)
02/2014 - 07/2003
5Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2012 - 11/2005
4Adenoma (Adenomas)
06/2021 - 03/2012
4Cushing Syndrome
01/2021 - 02/2004
4Hypertension (High Blood Pressure)
04/2017 - 01/2010
2Urologic Neoplasms (Urological Cancer)
10/2022 - 01/2022
2Testicular Germ Cell Tumor
01/2021 - 10/2020
2Diabetes Mellitus
01/2021 - 04/2017
2Urinary Calculi (Urinary Calculus)
01/2021 - 09/2005
2Hernia (Hernias)
03/2020 - 01/2009
2Infections
01/2019 - 12/2008
2Interstitial Cystitis (Interstitial Cystitis, Chronic)
05/2018 - 01/2017
2Pheochromocytoma
03/2016 - 02/2005
2Azoospermia
01/2016 - 06/2002
2Shock
06/2013 - 06/2008
1Leiomyosarcoma
10/2022
1Sarcoma (Soft Tissue Sarcoma)
10/2022
1Liposarcoma
10/2022

Drug/Important Bio-Agent (IBA)

35MicroRNAs (MicroRNA)IBA
12/2020 - 04/2011
30AndrogensIBA
01/2022 - 07/2003
21Hormones (Hormone)IBA
06/2022 - 09/2002
13Prostate-Specific Antigen (Semenogelase)IBA
01/2021 - 07/2003
11Androgen Receptors (Androgen Receptor)IBA
06/2022 - 05/2002
11Testosterone (Sustanon)FDA Link
01/2020 - 03/2005
10Proteins (Proteins, Gene)FDA Link
06/2021 - 11/2005
9RNA (Ribonucleic Acid)IBA
06/2021 - 01/2017
8Biomarkers (Surrogate Marker)IBA
04/2020 - 02/2005
7DNA (Deoxyribonucleic Acid)IBA
01/2021 - 06/2002
7Androgen Antagonists (Antiandrogens)IBA
09/2018 - 02/2004
5Docetaxel (Taxotere)FDA Link
06/2022 - 02/2014
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 07/2003
4Small Interfering RNA (siRNA)IBA
01/2021 - 01/2012
4AldosteroneIBA
01/2020 - 03/2012
4LigandsIBA
12/2014 - 11/2005
3Hydrocortisone (Cortisol)FDA LinkGeneric
06/2021 - 02/2004
3LipidsIBA
06/2021 - 12/2015
3Sunitinib (Sutent)FDA Link
01/2021 - 10/2014
3Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2017
3Tumor Biomarkers (Tumor Markers)IBA
01/2018 - 07/2006
3bicalutamide (Casodex)FDA LinkGeneric
05/2016 - 02/2004
3Antihypertensive Agents (Antihypertensives)IBA
10/2014 - 03/2012
3Alkaline PhosphataseIBA
02/2014 - 06/2010
3Zoledronic Acid (Zometa)FDA Link
11/2012 - 04/2008
3naftopidilIBA
09/2012 - 08/2008
3Diphosphonates (Bisphosphonates)IBA
09/2010 - 07/2006
3Matrix Metalloproteinases (MMPs)IBA
04/2008 - 09/2003
2CarbonIBA
10/2022 - 05/2006
2pembrolizumabIBA
07/2022 - 11/2021
2Essential Amino AcidsIBA
01/2022 - 09/2021
22- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acidIBA
01/2022 - 01/2020
2Leucine (L-Leucine)FDA Link
01/2022 - 01/2002
2Coloring Agents (Dyes)IBA
01/2022 - 05/2008
2Cisplatin (Platino)FDA LinkGeneric
11/2021 - 01/2016
2GemcitabineFDA Link
11/2021 - 04/2009
2Amino Acid Transport Systems (Amino Acid Transporter)IBA
09/2021 - 01/2020
2Messenger RNA (mRNA)IBA
09/2020 - 02/2004
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020 - 02/2014
2Indicators and Reagents (Reagents)IBA
11/2019 - 07/2006
2enzalutamideIBA
04/2019 - 05/2016
2SteroidsIBA
01/2018 - 02/2004
2EnzymesIBA
05/2016 - 07/2004
2CollagenIBA
05/2016 - 09/2003
2Vasopressins (Vasopressin)IBA
10/2015 - 02/2004
2Collagen Type I (Type I Collagen)IBA
11/2012 - 06/2010
2Analgesics (Analgesic Drugs)IBA
01/2010 - 11/2009
2C-Reactive ProteinIBA
01/2010 - 07/2006
2Pharmaceutical PreparationsIBA
11/2009 - 02/2005
2Insulin-Like Growth Factor I (IGF-1)IBA
02/2009 - 05/2006
2Nonsteroidal Anti-AndrogensIBA
09/2008 - 02/2004
2Flutamide (Eulexin)FDA LinkGeneric
09/2008 - 02/2004
2Tamsulosin (Flomax)FDA LinkGeneric
06/2008 - 09/2006
2Chromogranin AIBA
05/2008 - 08/2005
1Protons (Proton)IBA
10/2022
1IonsIBA
10/2022
1Oxygen (Dioxygen)IBA
10/2022
1Biological ProductsIBA
10/2022

Therapy/Procedure

52Therapeutics
10/2022 - 02/2002
25Castration
06/2022 - 02/2004
15Adrenalectomy
01/2021 - 02/2004
9Prostatectomy (Retropubic Prostatectomy)
01/2016 - 03/2005
8Heavy Ion Radiotherapy
10/2022 - 08/2012
8Drug Therapy (Chemotherapy)
01/2021 - 11/2006
7Nephrectomy
11/2021 - 12/2006
6Radiotherapy
07/2019 - 05/2006
4Nephroureterectomy
12/2019 - 11/2017
3Lithotripsy (Extracorporeal Shockwave Lithotripsy)
06/2013 - 09/2005
3Immunotherapy
01/2011 - 10/2009
3Lasers (Laser)
05/2009 - 02/2005
2Transurethral Resection of Bladder
10/2022 - 11/2020
2Lymph Node Excision (Lymph Node Dissection)
11/2021 - 11/2017
2Aftercare (After-Treatment)
09/2012 - 05/2007